Supreme Court Turns Down Athena v. Allergan; 'Torrent' Of Suits To Come?

Following the recommendation of Solicitor General Donald Verrilli, the Supreme Court has declined to review Allergan v. Athena Cosmetics, a case examining if the Federal Food, Drug and Cosmetic Act preempts an unfair competition claim in California characterizing Athena's RevitaLash products as unapproved drugs. Athena predicts a "torrent of novel and disruptive litigation" could ensue.

Courts may have a larger role in determining if a product should be regulated as a cosmetic or a drug following the Supreme Court's refusal to hear Athena Cosmetics, Inc. v. Allergan, Inc.

Athena's was one of numerous

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight